4//SEC Filing
Raptor Pharmaceutical Corp 4
Accession 0001140361-14-028107
CIK 0001070698operating
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 7:41 PM ET
Size
12.7 KB
Accession
0001140361-14-028107
Insider Transaction Report
Form 4
Keltner Llew
Director
Transactions
- Exercise/Conversion
Common Stock
2014-07-07$2.02/sh+9,490$19,170→ 9,490 total - Exercise/Conversion
Stock options (right to buy)
2014-07-07−9,490→ 2,488 totalExercise: $2.02Exp: 2020-03-09→ Common Stock (9,490 underlying) - Exercise/Conversion
Stock options (right to buy)
2014-07-07−510→ 29,490 totalExercise: $2.97Exp: 2020-10-12→ Common Stock (510 underlying) - Exercise/Conversion
Common Stock
2014-07-07$2.97/sh+510$1,515→ 10,000 total - Sale
Common Stock
2014-07-07$11.21/sh−10,000$112,129→ 0 total
Footnotes (4)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 14, 2013.
- [F2]Fully vested and exercisable.
- [F3]Stock options vest 6/48ths on February 28, 2011 and 1/48th per month thereafter.
- [F4]This transaction was executed in multiple trades at prices ranging from $10.89 to $11.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Raptor Pharmaceutical Corp
CIK 0001070698
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001070698
Filing Metadata
- Form type
- 4
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 7:41 PM ET
- Size
- 12.7 KB